Pfizer profits dipped on lower sales of Paxlovid.
Photo: Patrick T. Fallon / AFP/File
Source: AFP
Pfizer reported a dip in profits Tuesday, driven partly by lower sales of Covid-19 therapeutic drug Paxlovid, as it maintained a 2025 forecast that does not include potential tariff effects.
Pfizer profits dip on lower Paxlovid sales …C0NTINUE READING HERE >>>>